Works matching IS 2076393X AND DT 2025 AND VI 13 AND IP 2
Results: 222
Outer Membrane Proteins as Vaccine Targets Against Lawsonia intracellularis in Piglets.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 207, doi. 10.3390/vaccines13020207
- By:
- Publication type:
- Article
mRNA Galsomes Vaccine Protects Budgerigars Against Virulent Chlamydia psittaci Challenge.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 206, doi. 10.3390/vaccines13020206
- By:
- Publication type:
- Article
Memory Cells in Infection and Autoimmunity: Mechanisms, Functions, and Therapeutic Implications.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 205, doi. 10.3390/vaccines13020205
- By:
- Publication type:
- Article
Multivalent Inactivated Vaccine Protects Chickens from Distinct Clades of Highly Pathogenic Avian Influenza Subtypes H5N1 and H5N8.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 204, doi. 10.3390/vaccines13020204
- By:
- Publication type:
- Article
Assessing the Vulnerability of Splenectomized Patients to Severe COVID-19 Outcomes: A Systematic Review and Meta-Analysis.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 203, doi. 10.3390/vaccines13020203
- By:
- Publication type:
- Article
Advances and Challenges in Aeromonas hydrophila Vaccine Development: Immunological Insights and Future Perspectives.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 202, doi. 10.3390/vaccines13020202
- By:
- Publication type:
- Article
The Past, Present, and Future of Cervical Cancer Vaccines.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 201, doi. 10.3390/vaccines13020201
- By:
- Publication type:
- Article
Incidence of Pertussis in Older Children Underestimated in the Whole-Cell Vaccine Era: A Cross-Sectional Seroprevalence Study.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 200, doi. 10.3390/vaccines13020200
- By:
- Publication type:
- Article
Novel sACE2-Anti-CD16VHH Fusion Protein Surreptitiously Inhibits SARS-CoV-2 Variant Spike Proteins and Macrophage Cytokines, and Activates Natural Killer Cell Cytotoxicity.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 199, doi. 10.3390/vaccines13020199
- By:
- Publication type:
- Article
Achievement and Challenges in Orthohantavirus Vaccines.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 198, doi. 10.3390/vaccines13020198
- By:
- Publication type:
- Article
Early and Late Influenza Vaccine Effectiveness in South Korea During the 2023–2024 Season.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 197, doi. 10.3390/vaccines13020197
- By:
- Publication type:
- Article
Porvac ® Subunit Vaccine Protects Against Three Field Isolates of Classical Swine Fever Virus.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 196, doi. 10.3390/vaccines13020196
- By:
- Publication type:
- Article
Amonabactin Synthetase G Regulates Aeromonas hydrophila Pathogenicity Through Modulation of Host Wnt/β-catenin Signaling.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 195, doi. 10.3390/vaccines13020195
- By:
- Publication type:
- Article
Sex and Age-Based Differences in Immune Responses to a Peptide Vaccine for Melanoma in Two Clinical Trials.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 194, doi. 10.3390/vaccines13020194
- By:
- Publication type:
- Article
Innate Sensing of Viral Nucleic Acids and Their Use in Antiviral Vaccine Development.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 193, doi. 10.3390/vaccines13020193
- By:
- Publication type:
- Article
Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 192, doi. 10.3390/vaccines13020192
- By:
- Publication type:
- Article
Molecular Farming for Immunization: Current Advances and Future Prospects in Plant-Produced Vaccines.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 191, doi. 10.3390/vaccines13020191
- By:
- Publication type:
- Article
Long-Term Protection in Atlantic Salmon (Salmo salar) to Pancreas Disease (PD) Can Be Achieved Through Immunization with Genetically Modified, Live Attenuated Salmonid Alphavirus 3.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 190, doi. 10.3390/vaccines13020190
- By:
- Publication type:
- Article
Safety and Efficacy of Influenza Vaccination in Kidney Graft Recipients in Late Period After Kidney Transplantation.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 189, doi. 10.3390/vaccines13020189
- By:
- Publication type:
- Article
Generation of Vaccine Candidate Strains That Antigenically Match Classical Swine Fever Virus Field Strains.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 188, doi. 10.3390/vaccines13020188
- By:
- Publication type:
- Article
Cost-Effectiveness of Introducing Nuvaxovid to COVID-19 Vaccination in the United Kingdom: A Dynamic Transmission Model.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 187, doi. 10.3390/vaccines13020187
- By:
- Publication type:
- Article
Correction: Patel et al. Development and Characterization of an In Vitro Cell-Based Assay to Predict Potency of mRNA–LNP-Based Vaccines. Vaccines 2023, 11 , 1224.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Current Development of Therapeutic Vaccines in Lung Cancer.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 185, doi. 10.3390/vaccines13020185
- By:
- Publication type:
- Article
Immunosuppressive Treatments and Risk Factors Associated with Non-Response to Hepatitis B Vaccination: A Cohort Study.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 184, doi. 10.3390/vaccines13020184
- By:
- Publication type:
- Article
Prevalence of Mpox Vaccine Acceptance Among Students: A Systematic Review and Meta-Analysis.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 183, doi. 10.3390/vaccines13020183
- By:
- Publication type:
- Article
HDAC3: A Multifaceted Modulator in Immunotherapy Sensitization.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 182, doi. 10.3390/vaccines13020182
- By:
- Publication type:
- Article
Plasma microRNAs to Select Optimal Patients for Antibody Production from Anti-Addiction Vaccines.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 181, doi. 10.3390/vaccines13020181
- By:
- Publication type:
- Article
Novel Standard Substance from Primary Hamster Kidney Cells for Quality Control of Human Rabies Vaccines in China.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 180, doi. 10.3390/vaccines13020180
- By:
- Publication type:
- Article
Leveraging Electron Beam (eBeam) Technology for Advancing the Development of Inactivated Vaccines.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 179, doi. 10.3390/vaccines13020179
- By:
- Publication type:
- Article
In Situ Tumor Vaccination Using Lipid Nanoparticles to Deliver Interferon-β mRNA Cargo.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 178, doi. 10.3390/vaccines13020178
- By:
- Publication type:
- Article
The Efficacy and Safety of Simultaneous Vaccination with Polysaccharide Conjugate Vaccines Against Pneumococcal (13-Valent Vaccine) and Haemophilus influenzae Type b Infections in Children with Juvenile Idiopathic Arthritis Without Systemic Manifestations: A Prospective Cohort Study
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 177, doi. 10.3390/vaccines13020177
- By:
- Publication type:
- Article
COVID-19 Vaccination and Acute Anterior Uveitis—A Case Control Study.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 176, doi. 10.3390/vaccines13020176
- By:
- Publication type:
- Article
Nirsevimab Prophylaxis for Reduction of Respiratory Syncytial Virus Complications in Hospitalised Infants: The Multi-Centre Study During the 2023–2024 Season in Andalusia, Spain (NIRSEGRAND).
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 175, doi. 10.3390/vaccines13020175
- By:
- Publication type:
- Article
Increasing Prevalence of Occult HBV Infection in Adults Vaccinated Against Hepatitis B at Birth.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 174, doi. 10.3390/vaccines13020174
- By:
- Publication type:
- Article
Effect of Inoculation Volume on a Mouse Model of Influenza Virus Infected with the Same Viral Load.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 173, doi. 10.3390/vaccines13020173
- By:
- Publication type:
- Article
Human Papillomavirus Infection in Partners of Women Attending Cervical Cancer Screening: A Pilot Study on Prevalence, Distribution, and Potential Use of Vaccines.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 172, doi. 10.3390/vaccines13020172
- By:
- Publication type:
- Article
Adherence to Palivizumab for Respiratory Syncytial Virus Prophylaxis in Romanian Infants.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 171, doi. 10.3390/vaccines13020171
- By:
- Publication type:
- Article
The Humoral Immune Response Against COVID-19 Through Vaccination in Hemodialysis Patients.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 170, doi. 10.3390/vaccines13020170
- By:
- Publication type:
- Article
Efficacy of Inactivated Bivalent SARS-CoV-2 Vaccines Targeting Ancestral Strain (ERAGEM), Delta, and Omicron Variants.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 169, doi. 10.3390/vaccines13020169
- By:
- Publication type:
- Article
Enhanced and Prolonged Immunogenicity in Mice of Thermally Stabilized Fatty Acid-Conjugated Vaccine Antigen.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 168, doi. 10.3390/vaccines13020168
- By:
- Publication type:
- Article
Further Insights into the Measurement of Free Polysaccharide in Meningococcal Conjugate Vaccines.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 167, doi. 10.3390/vaccines13020167
- By:
- Publication type:
- Article
Effectiveness of Heterologous and Homologous Ad26.COV2.S Vaccine Boosting in Preventing COVID-19-Related Outcomes Among Individuals with a Completed Primary Vaccination Series in the United States.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 166, doi. 10.3390/vaccines13020166
- By:
- Publication type:
- Article
Invasive Meningococcal Disease in the Post-COVID World: Patterns of Disease Rebound.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 165, doi. 10.3390/vaccines13020165
- By:
- Publication type:
- Article
Effect of Current-Season-Only Versus Continuous Two-Season Influenza Vaccination on Mortality in Older Adults: A Propensity-Score-Matched Retrospective Cohort Study.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 164, doi. 10.3390/vaccines13020164
- By:
- Publication type:
- Article
Longitudinal Surveillance of COVID-19 Antibodies in Pediatric Healthcare Workers.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 163, doi. 10.3390/vaccines13020163
- By:
- Publication type:
- Article
P23-Specific IgY Significantly Reduces Diarrhea and Oocyst Shedding in Calves Experimentally Infected with Cryptosporidium parvum.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 162, doi. 10.3390/vaccines13020162
- By:
- Publication type:
- Article
Prevalence of Adverse Events Reported Following the First Dose of COVID-19 Vaccines in Bahia State, Brazil, from 2021 to 2022.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 161, doi. 10.3390/vaccines13020161
- By:
- Publication type:
- Article
Analysis on the Epidemiological Characteristics of Breakthrough Varicella Cases and Incremental Effectiveness of 2-Dose Varicella Vaccine in China.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 160, doi. 10.3390/vaccines13020160
- By:
- Publication type:
- Article
Knowledge and Attitudes Regarding Respiratory Syncytial Virus (RSV) Prevention: A Systematic Review.
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 159, doi. 10.3390/vaccines13020159
- By:
- Publication type:
- Article
Safety and Immunogenicity of Concomitant Administration and Combined Administration of Bivalent BNT162b2 COVID-19 Vaccine and Bivalent RSVpreF Respiratory Syncytial Virus Vaccine with or Without Quadrivalent Influenza Vaccine in Adults ≥ 65 Years of Age
- Published in:
- Vaccines, 2025, v. 13, n. 2, p. 158, doi. 10.3390/vaccines13020158
- By:
- Publication type:
- Article